fbpx
Loading...

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations

STICs and STONEs is a randomised, Phase II, double-blind, placebo-controlled trial of aspirin in the prevention of ovarian cancer in women with BRCA1 and BRCA2 mutations. Prof Phillips, Principal Investigator of STICs and STONEs, [...]

Exploring aspirin as an ovarian cancer preventative for women with BRCA 1/2 mutations2021-09-28T03:53:44+10:00

Honour Her live auction launch announcement features on ABC Breakfast News

Honour Her, a campaign led by ANZGOG's fundraising arm WomenCan, has been raising funds throughout September for ANZGOG’s gynaecological cancer research by showcasing the work of emerging artists in a virtual gallery. In addition to this, [...]

Honour Her live auction launch announcement features on ABC Breakfast News2021-09-28T03:37:18+10:00

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study

A new journal has been published by the National Library of Medicine for ANZGOG's MOST-S26 study. The Measure of Ovarian Symptoms and Treatment study (MOST-S26) detected an improvement in symptoms of peripheral neuropathy, psychological [...]

Dr Rachel Campbell discusses findings from a new publication for the MOST-S26 study2021-09-15T00:55:56+10:00

HyNOVA trial opens to recruitment

The HyNOVA study has officially opened to recruitment after activating its first site, Peter MacCallum Cancer Centre and Royal Women’s Hospital. Researchers of the HyNOVA study are seeking 80 participants at five sites across [...]

HyNOVA trial opens to recruitment2021-09-02T06:02:56+10:00
Go to Top